Exact Sciences Corp

EXK

Company Profile

  • Business description

    Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

  • Contact

    5505 Endeavor Lane
    MadisonWI53719
    USA

    T: +1 608 284-5700

    E: [email protected]

    https://www.exactsciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    7,000

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,820.306.40-0.07%
CAC 407,820.7581.50-1.03%
DAX 4024,191.32265.49-1.09%
Dow JONES (US)44,650.64192.340.43%
FTSE 1008,921.4754.19-0.60%
HKSE24,139.57111.200.46%
NASDAQ20,630.6619.330.09%
Nikkei 22539,569.6876.68-0.19%
NZX 50 Index12,686.6873.52-0.58%
S&P 5006,280.4617.200.27%
S&P/ASX 2008,580.109.10-0.11%
SSE Composite Index3,510.180.500.01%

Market Movers